"Thanks to our partners at @readysetrocket! #ommaawards"
  1. Hispanics are driving the growth in headache/pain remedies.
    Hispanics accounted for 1 out of every 3 new headache/pain remedy users from 2006 – 2010.
    Source: Simmons NCS/NHCS: Fall 2006 – 2010 Adult Full Year – Pop, Base: A18+
  2. Hispanics are more likely to use children’s OTC remedies.
    Thirty-five percent of Hispanics use children’s fever/pain relievers vs. 23% of Non-Hispanics; and 29% of Hispanics use children’s cough/cold products vs. 17% of Non-Hispanics.
    Source: Simmons NCS/NHCS: Fall 2010 Adult Full Year – Pop, Base: A18+
  3. The importance of familia extends to health concerns.
    Sixty-two percent of Hispanics “worry about the health of other family members” vs. 47% of Non-Hispanic Whites. The concern also covers the idea of providing care as 42% of Hispanics vs. 23% of Non-Hispanic Whites are worried about “taking care of elderly family members”.
    Source: Yankelovich MONITOR Multicultural Study 2010, Base: Persons 16+
  4. Hispanics are less likely to use private label OTC remedies.
    Private label captures 27% of Hispanic cold/allergy/sinus remedy sales vs. 33% of Non-Hispanic sales. For internal analgesics, private label accounts for 33% of Hispanic sales vs. 38% of Non-Hispanic sales.
    Source: IRI Ethnic Workbench Scan Data – 52 Weeks Ending 6/26/201, Cold/Allergy/Sinus Liquids/Tablets and Internal Analgesics categories.
  5. Hispanic OTC sales offer over 1 billion dollars in incremental growth opportunity.
    Hispanics currently contribute $2.1 Billion or 11% of total U.S. OTC sales. Reaching census parity would see this number grow to $3.5 Billion.
    Source: IRI Ethnic Workbench Scan Data – 52 Weeks Ending 6/26/201 based on 19 OTC categories.
  • This field is for validation purposes and should be left unchanged.
7ads6x98y